The DOI matches its Crossref record.
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.
Abstract
PURPOSE: To evaluate a strategy that avoids radiotherapy in children less than 6 years of age with newly diagnosed malignant brain tumors, by administering myeloablative consolidation chemotherapy with autologous bone marrow reconstitution (ABMR) after maximal surgical resection and conventional induction chemotherapy. PATIENTS AND METHODS: Between March 1991 and April 1995, 62 children (median age, 30 months) with newly diagnosed malignant brain tumors were enrolled onto this trial. Children received conventional induction chemotherapy with vincristine, cisplatin, cyclophosphamide, and etoposide, repeated every 3 weeks for five cycles. Children without disease progression on induction chemotherapy were offered consolidation with myeloablative chemotherapy that incorporated carboplatin, thiotepa, and etoposide followed by ABMR. Irradiation was used only for residual tumor at consolidation or for progressive/recurrent disease. RESULTS: Induction chemotherapy was well tolerated by most patients; however, progression was noted in 17 children (27%) and four (6%) died of treatment complications. Of 37 children who received consolidation chemotherapy with ABMR, 15 are free of disease progression (median post-ABMR without further treatment, >44 months). The remaining 22 all progressed within 15 months of ABMR; three of 37 (8%) died of treatment-related complications. The 3-year overall survival (OS) and event-free survival (EFS) rates from diagnosis for all children are 40% (95% confidence interval [CI], 28% to 52%) and 25% (95% CI, 13% to 37%), respectively. Radiotherapy was administered to 19 of 62 children: 17 for progressive disease (PD) and two for residual disease at the time of ABMR. CONCLUSION: A significant proportion of children with malignant brain tumors can avoid radiotherapy and prolonged maintenance chemotherapy yet still achieve durable remission with this brief intensive chemotherapy regimen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Buckner, J. C., Brown, P. D., O'Neill, B. P., Meyer, F. B., Wetmore, C. J., & Uhm, J. H. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.10.1271 · Cited by 341
Packer, R. J., Gurney, J. G., Punyko, J. A., Donaldson, S. S., Inskip, P. D., Stovall, M., Yasui, Y., Mertens, A. C., Sklar, C. A., Nicholson, H. S., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.202 · Cited by 338
Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis
Rutkowski, S., von Hoff, K., Emser, A., Zwiener, I., Pietsch, T., Figarella-Branger, D., Giangaspero, F., Ellison, D. W., Garre, M.-L., Biassoni, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2299 · Cited by 323
Self-citationBagchi, A., Dhanda, S. K., Dunphy, P., Sioson, E., & Robinson, G. W. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.7024 · Cited by 28
Metadata
- Authors
- Mason, W. P., Grovas, A., Halpern, S., Dunkel, I. J., Garvin, J., Heller, G., Rosenblum, M., Gardner, S., Lyden, D., Sands, S., Puccetti, D., Lindsley, K., Merchant, T. E., O'Malley, B., Bayer, L., Petriccione, M. M., Allen, J., & Finlay, J. L.
- Venue
- Journal of Clinical Oncology
- Published
- 1998-01
- Volume
- 16
- Issue
- 1
- Pages
- 210-221
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2180612211
- Cited by
- 239
- References
- 0
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. https://app.cochat.ai/papers/10.1200/jco.1998.16.1.210
- The paper
- Mason, W. P., Grovas, A., Halpern, S., Dunkel, I. J., Garvin, J., Heller, G., Rosenblum, M., Gardner, S., Lyden, D., Sands, S., Puccetti, D., Lindsley, K., Merchant, T. E., O'Malley, B., Bayer, L., Petriccione, M. M., Allen, J., & Finlay, J. L. (1998). Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1998.16.1.210
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.